Reliq Health Technologies Income Statement

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '23 Mar 31, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018
Revenue	14.62	8.55	1.46	1.14	0.18	2.27
Revenue Growth (YoY)	119.37%	484.87%	27.92%	528.36%	-91.98%	1142.52%
Cost of Revenue	5.76	3.25	0.6	0.97	0.17	1.12
Gross Profit	8.86	5.3	0.86	0.17	0.01	1.15
Selling, General & Admin	5.27	4.94	7.07	7.7	6.2	4.29
Research & Development	3.09	2.22	1.73	1.72	5.15	1.42
Amortization of Goodwill & Intangibles	0.12	0.12	0.13	0.45	0.6	-
Operating Expenses	10.19	13.52	12.42	11.33	13.31	14.78
Operating Income	-1.33	-8.22	-11.56	-11.16	-13.31	-13.63
Interest Expense	-0.03	-0.04	-0.05	-0.04	-	-
Interest & Investment Income	0.47	0.08	-	-	-	-
Currency Exchange Gain (Loss)	0.49	0.08	-0.1	-0.02	-0.02	0.02
Other Non Operating Income (Expenses)	-0.06	-0.07	-0.08	-0.07	-0.08	-0.16
EBT Excluding Unusual Items	-0.46	-8.17	-11.78	-11.28	-13.4	-13.77
Gain (Loss) on Sale of Assets	-	-	-	0.16	-	-
Other Unusual Items	-	-	-	-	0.4	-0.03
Pretax Income	-0.46	-8.17	-11.78	-11.12	-13	-13.8
Net Income	-0.46	-8.17	-11.78	-11.12	-13	-13.8
Net Income to Common	-0.46	-8.17	-11.78	-11.12	-13	-13.8
Shares Outstanding (Basic)	186	183	158	135	118	95
Shares Outstanding (Diluted)	186	183	158	135	118	95
Shares Change (YoY)	0.89%	15.96%	16.77%	14.19%	24.13%	59.30%
EPS (Basic)	-0.00	-0.04	-0.07	-0.08	-0.11	-0.14
EPS (Diluted)	-0.00	-0.04	-0.07	-0.08	-0.11	-0.14
Free Cash Flow	-6.85	-8.03	-7.11	-6.31	-11.96	-8.15
Free Cash Flow Per Share	-0.04	-0.04	-0.04	-0.05	-0.10	-0.09
Gross Margin	60.61%	61.99%	58.68%	15.25%	4.31%	50.52%
Operating Margin	-9.10%	-96.14%	-790.41%	-975.99%	-7314.43%	-600.72%
Profit Margin	-3.13%	-95.55%	-805.69%	-973.06%	-7148.79%	-607.92%
Free Cash Flow Margin	-46.87%	-93.88%	-485.99%	-551.82%	-6576.81%	-359.16%
EBITDA	-1.21	-8.11	-11.48	-10.82	-12.67	-13.63
EBITDA Margin	-8.27%	-94.79%	-	-	-	-
D&A For EBITDA	0.12	0.12	0.08	0.34	0.63	0
EBIT	-1.33	-8.22	-11.56	-11.16	-13.31	-13.63
EBIT Margin	-9.10%	-96.14%	-	-	-	-
Revenue as Reported	14.62	8.55	1.46	1.14	-	-
Advertising Expenses	-	0.49	0.51	0.28	0.27	0.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.